PD-L1 Expression in Neoplastic and Immune Cells of Thymic Epithelial Tumors: Correlations with Disease Characteristics and HDAC Expression
IE Stergiou, K Palamaris, G Levidou, M Tzimou… - Biomedicines, 2024 - mdpi.com
Background: Programmed death-ligand 1 (PD-L1) expression in neoplastic and immune
cells of the tumor microenvironment determines the efficacy of antitumor immunity, while it …
cells of the tumor microenvironment determines the efficacy of antitumor immunity, while it …
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies
F Lococo, E De Paolis, J Evangelista, A Dell'Amore… - 2024 - preprints.org
Conclusions: CGP do not substantially differ between initial tumor vs tumor recurrence and
recurrent thymomas vs non-recurrent thymomas. Cell-cycle control genes alterations are …
recurrent thymomas vs non-recurrent thymomas. Cell-cycle control genes alterations are …